Dr Lauren Mikesell Panebianco, MD in East Syracuse, NY - Medicare Hematology/oncology

Dr Lauren Mikesell Panebianco, MD is a medicare enrolled "Internal Medicine - Hematology & Oncology" physician in East Syracuse, New York. She went to State University Of Ny Upstate Medical University and graduated in 2013 and has 11 years of diverse experience with area of expertise as Hematology/oncology. She is a member of the group practice Hematology-oncology Associates Of Cny, Pc and her current practice location is 5008 Brittonfield Pkwy Ste 700, East Syracuse, New York. You can reach out to her office (for appointments etc.) via phone at (315) 472-7504.

Dr Lauren Mikesell Panebianco is licensed to practice in New York (license number 284318) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1770921991.

Contact Information

	Dr Lauren Mikesell Panebianco, MD
	5008 Brittonfield Pkwy Ste 700, East Syracuse, NY 13057-9249
	(315) 472-7504
	Not Available

Physician's Profile

Full Name	Dr Lauren Mikesell Panebianco
Gender	Female
Speciality	Hematology/oncology
Experience	11 Years
Location	5008 Brittonfield Pkwy Ste 700, East Syracuse, New York
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Lauren Mikesell Panebianco attended and graduated from State University Of Ny Upstate Medical University in 2013

NPI Data:

NPI Number: 1770921991
Provider Enumeration Date: 06/10/2013
Last Update Date: 06/17/2020

Medicare PECOS Information:

PECOS PAC ID: 1759628381
Enrollment ID: I20200908000467

Medical Identifiers

Medical identifiers for Dr Lauren Mikesell Panebianco such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1770921991	NPI	-	NPPES
284318	Other		LICENSE

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RH0003X	Internal Medicine - Hematology & Oncology	284318 (New York)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Hospice Of Central New York	Liverpool, NY	Hospice
University Hospital S U N Y Health Science Center	Syracuse, NY	Hospital
Crouse Hospital	Syracuse, NY	Hospital
St Joseph's Hospital Health Center	Syracuse, NY	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Hematology-oncology Associates Of Cny, Pc	6709787823	55

News Archive

Sarsia Seed provides follow-up funding for APIM Therapeutics

APIM Therapeutics AS, an early-stage Norwegian therapeutic company, is pursuing a novel drug approach with the ability to potentiate the action of a wide range of chemotherapeutic drugs currently used to treat several types of cancer.

Low income women less likely to be screened for cancer in Ontario

Less than half of Ontario women with abnormal Pap tests receive recommended and potentially life-saving follow-up care, according to a new women's health study by researchers at St. Michael's Hospital and the Institute for Clinical Evaluative Sciences (ICES). What's more, low-income women are less likely to be screened for cancer compared to their high-income counterparts.

Advisory panel recommends FDA approve new "morning after" pill

The New York Times: A Food and Drug Administration advisory panel Thursday recommended that the agency approve "a medicine that could help prevent pregnancy if taken as late as five days after unprotected sex. The pill, called ella, sprang from government labs and appears to be more effective than Plan B, a morning-after pill now available over the counter to women 18 and older that gradually loses efficacy after intercourse and can be taken at latest three days after sex.

TUM scientists develop new pH sensor that provides insights into tumor metabolism

Tumors, inflammation and circulatory disorders locally disturb the body's acid-base balance. These changes in pH value could be used for example to verify the success of cancer treatments.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Lauren Mikesell Panebianco allows following entities to bill medicare on her behalf.

Entity Name	Hematology-oncology Associates Of Cny, Pc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1902885429 PECOS PAC ID: 6709787823 Enrollment ID: O20040120000679

News Archive

Sarsia Seed provides follow-up funding for APIM Therapeutics

Low income women less likely to be screened for cancer in Ontario

Advisory panel recommends FDA approve new "morning after" pill

TUM scientists develop new pH sensor that provides insights into tumor metabolism

Tumors, inflammation and circulatory disorders locally disturb the body's acid-base balance. These changes in pH value could be used for example to verify the success of cancer treatments.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Lauren Mikesell Panebianco is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Lauren Mikesell Panebianco, MD 5008 Brittonfield Pkwy Ste 700, East Syracuse, NY 13057-9249 Ph: (315) 472-7504	Dr Lauren Mikesell Panebianco, MD 5008 Brittonfield Pkwy Ste 700, East Syracuse, NY 13057-9249 Ph: (315) 472-7504

News Archive

Sarsia Seed provides follow-up funding for APIM Therapeutics

Low income women less likely to be screened for cancer in Ontario

Advisory panel recommends FDA approve new "morning after" pill

TUM scientists develop new pH sensor that provides insights into tumor metabolism

Tumors, inflammation and circulatory disorders locally disturb the body's acid-base balance. These changes in pH value could be used for example to verify the success of cancer treatments.

Internal Medicine Doctors in East Syracuse, NY

Anthony J Scalzo, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5008 Brittonfield Pkwy, Suite 700, East Syracuse, NY 13057 Phone: 315-472-7504 Fax: 315-479-8639
Marcel Daniel Bingham, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5008 Brittonfield Pkwy, Suite 700, East Syracuse, NY 13057 Phone: 315-472-7504 Fax: 315-479-8639
Angelie D Roman, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 5008 Brittonfield Pkwy, Suite 700, East Syracuse, NY 13057 Phone: 315-472-7504 Fax: 315-479-8639
Steven V Zygmont, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5000 Brittonfield Pkwy Ste A100, East Syracuse, NY 13057 Phone: 315-449-3800 Fax: 315-449-0558
David A Churchill, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 5008 Brittonfield Pkwy, Suite 700, East Syracuse, NY 13057 Phone: 315-472-7504 Fax: 315-479-8639
Dr. Steven M Duffy, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5008 Brittonfield Pkwy Ste 700, East Syracuse, NY 13057 Phone: 315-472-7504 Fax: 315-634-4677
Ms. Brooke Nicole Binion, PA-C Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5008 Brittonfield Pkwy Ste 700, East Syracuse, NY 13057 Phone: 315-472-7504

Dr Lauren Mikesell Panebianco, MD - Medicare Hematology/oncology in East Syracuse, NY

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Sarsia Seed provides follow-up funding for APIM Therapeutics

Low income women less likely to be screened for cancer in Ontario

Advisory panel recommends FDA approve new "morning after" pill

TUM scientists develop new pH sensor that provides insights into tumor metabolism

Medicare Reassignments

Sarsia Seed provides follow-up funding for APIM Therapeutics

Low income women less likely to be screened for cancer in Ontario

Advisory panel recommends FDA approve new "morning after" pill

TUM scientists develop new pH sensor that provides insights into tumor metabolism

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Sarsia Seed provides follow-up funding for APIM Therapeutics

Low income women less likely to be screened for cancer in Ontario

Advisory panel recommends FDA approve new "morning after" pill

TUM scientists develop new pH sensor that provides insights into tumor metabolism

Internal Medicine Doctors in East Syracuse, NY